108 related articles for article (PubMed ID: 3910836)
1. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis.
Clark S; Tindall E; Bennett RM
J Rheumatol; 1985 Oct; 12(5):980-3. PubMed ID: 3910836
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
Holman AJ; Myers RR
Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
[TBL] [Abstract][Full Text] [Related]
4. Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial.
Yunus MB; Masi AT; Aldag JC
J Rheumatol; 1989 Apr; 16(4):527-32. PubMed ID: 2664173
[TBL] [Abstract][Full Text] [Related]
5. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo.
Biasi G; Manca S; Manganelli S; Marcolongo R
Int J Clin Pharmacol Res; 1998; 18(1):13-9. PubMed ID: 9604730
[TBL] [Abstract][Full Text] [Related]
6. Fibromyalgia treatment with intravenous tropisetron administration.
Stratz T; Färber L; Varga B; Baumgartner C; Haus U; Müller W
Drugs Exp Clin Res; 2001; 27(3):113-8. PubMed ID: 11447769
[TBL] [Abstract][Full Text] [Related]
7. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
[TBL] [Abstract][Full Text] [Related]
8. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study.
Moldofsky H; Lue FA; Mously C; Roth-Schechter B; Reynolds WJ
J Rheumatol; 1996 Mar; 23(3):529-33. PubMed ID: 8832997
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Raloxifen in treatment of fibromyalgia in menopausal women.
Sadreddini S; Molaeefard M; Noshad H; Ardalan M; Asadi A
Eur J Intern Med; 2008 Jul; 19(5):350-5. PubMed ID: 18549938
[TBL] [Abstract][Full Text] [Related]
10. Endocrine control of inflammation: rheumatoid arthritis double-blind, crossover clinical trial.
Stenberg VI; Fiechtner JJ; Rice JR; Miller DR; Johnson LK
Int J Clin Pharmacol Res; 1992; 12(1):11-8. PubMed ID: 1526694
[TBL] [Abstract][Full Text] [Related]
11. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
Scharf MB; Baumann M; Berkowitz DV
J Rheumatol; 2003 May; 30(5):1070-4. PubMed ID: 12734908
[TBL] [Abstract][Full Text] [Related]
12. Low dose prednisone therapy in rheumatoid arthritis: a double blind study.
Harris ED; Emkey RD; Nichols JE; Newberg A
J Rheumatol; 1983 Oct; 10(5):713-21. PubMed ID: 6358491
[TBL] [Abstract][Full Text] [Related]
13. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms.
Shoemaker RC; House DE
Neurotoxicol Teratol; 2006; 28(5):573-88. PubMed ID: 17010568
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone.
Eberhardt R; Krüger K; Reiter W; Gross W; Zwingers T
Arzneimittelforschung; 1994 May; 44(5):642-7. PubMed ID: 8024639
[TBL] [Abstract][Full Text] [Related]
15. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.
van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
Arthritis Rheum; 2004 Apr; 51(2):233-8. PubMed ID: 15077265
[TBL] [Abstract][Full Text] [Related]
16. The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study.
Hamaty D; Valentine JL; Howard R; Howard CW; Wakefield V; Patten MS
J Rheumatol Suppl; 1989 Nov; 19():164-8. PubMed ID: 2532682
[TBL] [Abstract][Full Text] [Related]
17. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.
Bennett RM; Gatter RA; Campbell SM; Andrews RP; Clark SR; Scarola JA
Arthritis Rheum; 1988 Dec; 31(12):1535-42. PubMed ID: 3058130
[TBL] [Abstract][Full Text] [Related]
18. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
Färber L; Stratz TH; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Welzel D; Müller W;
Int J Clin Pharmacol Res; 2001; 21(1):1-13. PubMed ID: 11708570
[TBL] [Abstract][Full Text] [Related]
19. Double-blind crossover study to evaluate the efficacy of a single daily dose of naproxen in rheumatoid arthritis.
Katona G; Vargas RB
Eur J Rheumatol Inflamm; 1983; 6(3):233-41. PubMed ID: 6391928
[TBL] [Abstract][Full Text] [Related]
20. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
